Site Search

 

 

 

 

 

Home
General Topics
       What is Dialysis?
       Residual Renal Function
          The Importance of RRF
       Diabetes Management
          PD and the Diabetic Patient
          General Facts: Diabetes
       Renal Osteodystrophy
          Renal Osteodystrophy Clinical Studies
       Numbers-Their Use and Interpretation
       Basic Statistics
       Other
          Vaccinating CKD and Dialysis Patients
          32 yr dialysis patient receives Achievement award
Peritoneal Dialysis
       History of PD
          PD - The Foundations
          Early Clinical Experiences with PD
       Basic Principles of PD
          Anatomy of the Peritoneum
          Physiology of the Peritoneum
       Peritoneal Transport 
          Understanding Testing Methods
          Transport Status:Classification and Implications
          Peritoneal Function After Exposure to PD
       Modalities of Therapy
          PD Techniques
          PD Modalities
       PD Adequacy
          Prescribing Dialysis
             Targets of PD Prescription
             Determinants of Dose
             Exchange Volume and Position
             How to Reach the Goals
             Monitoring the PD Patient
             Evaluating the Patient as a Whole
             StdKt/V - Dose Equivalency
       Ultrafiltration
          Importance of Volume Control
          How to Achieve Adequate PD UF
       Clinical Procedures
       Complications
          Non-Infectious Complications of PD
          Peritoneal Dialysis-Related Infections
             Management of ESI
             Diagnosis and Treatment of Peritonitis 
       Dialysis Access
          The Evolution of PD Catheters
          Preop Management
          Placement of PD Catheters
          Intraoperative Management
          Post Operative Care and Management
          Complications of PD Catheters
       Clinical Outcomes
          Clinical outcomes of PD and HD
       Peritoneal Dialysis in Children
          Pediatric ESRD Incidence, Prevalence and Mortality
          Management of the pediatric patient on PD
          Utilization of PD for Acute Renal Failure and ESRD
          Prescription principles, adequacy and PET
          Additional care considerations: Nutrition, Growth,
       PD in the ICU
       Home Program Management
Hemodialysis
       History of Hemodialysis
       Kinetic Principles
          Impact of t & Kr on Kt/V
          StdKt/V - Dose Equivalency
       Modalities of Therapy
          Hemodialysis Regimens/Prescriptions
          Extracorporeal Modalities
       Home HD
          Introduction
          HD Regimens/Prescriptions
          The Influence of Dose, Time & Frequency
          Every other day HD (HD3.5)
          Time Versus Dialysis-Free Interval
          Benefits of Increased HD Frequency
          Increased Frequency – Other Modalities
          Potential Lifestyle Benefits of HD3.5
          Home Program Management
             Establishing a Home Program
       Intradialytic Complications
       Adequacy
          Difficulties in Prescribing Adequate Dialysis
       Sodium Modeling
       Hemodialysis Access
          Introduction to Vascular Access
          Overview of Arteriovenous Fistula
          Overview of Arteriovenous Grafts
          Overview of Central Venous Catheters
          Vascular Access Monitoring and Surveillance
       Access Complications
          Overview of Hemodialysis Complications
          AVF Stenosis
          Interventions for AVF and AVG Stenosis
          Primary Fistula Failure
          Catheter Related Bacteremia
Sorbent Technology
       History of Sorbent Technology
Seminars & Education
Educational Initiatives
Training Resources
       Kidney Options Kidney Options
       Patient Training Resources
       Training Resources for Professionals Training Resources for Professionals
Product Information
       Peritoneal Dialysis
          Fresenius Peritoneal Dialysis Connections
          WebEx Teleconference Workshops
       Hemodialysis
       Home Hemodialysis
Glossary
Links
       Journals
       Organizations
       Other Links
Contact Information
Calendar of Events
Contributors

Are the Renal and Peritoneal Contributions to Solute and Fluid Removal Equivalent?

Download to PDF

The KDOQI guidelines and most similar guidelines for adequacy quantitate the described dose as weekly total Kt/V or weekly creatinine clearance (Ccr).  This method of bundling peritoneal and renal clearances presupposes that both entities are equivalent.  A review of the literature very much suggests the contrary – peritoneal and renal function are not equivalent.

 

In 1995, Maiorca et al. showed that the persistence of RRF conferred a survival advantage to PD patients1.  In a large, cross-sectional study Diaz-Buxo et al. for the first time showed that RRF was strongly correlated with survival but peritoneal function was not2 (Table I).  Two likely explanations were offered for this finding: 1) The relatively narrow range of peritoneal doses provided did not allow sufficient change to affect survival rates; and, 2) The possibility that RRF is so superior to peritoneal function, that its presence may obliterate the effect of peritoneal clearance on survival. 

 

 Table I.  Association of renal and peritoneal creatinine clearance (Ccr) with odds of death using three logistic models2.

 

 

Cp (n=673)

Cr (n=559)

Cpr (n=443)

Variable

X2

p

OR

X2

p

OR

X2

p

OR

 

 

 

 

 

 

 

 

 

 

Age

30.2

<.001

1.046

26.8

<.001

1.054

13.2

<.001

1.042

Sex (M)

1.7

ns

0.750

2.1

ns

0.691

1.7

ns

0.689

Race (nW)

2.5

ns

1.512

3.8

.050

1.833

2.8

.092

1.881

DM (no)

11.0

<.001

2.023

12.0

<.001

2.431

14.4

<.001

2.991

 

 

 

 

 

 

 

 

 

 

Kp (L/wk)

1.0

ns

1.009

 

 

 

0.5

ns

1.008

Kr (L/wk)

 

 

 

12.7

<.001

0.876

8.9

.003

0.887

 

 

Several recent studies have shown a significant correlation between RRF and survival for both PD2-6 and HD7,8.  Table II summarizes the relative contribution of RRF to PD survival. 

 

Table II.  Relative contribution of residual renal function to survival in peritoneal dialysis

 

Reference

Year

n

1 ml/min

Reduction

RR (%)

 

Diaz-Buxo et al.2

1999

2686

Ccr

12

Szeto et al.3

2000

270

GFR

35

Rocco et al.4

2000

1512

Ccr

40

Bargman et al.5

2001

601

GFR

12

Termorshuizen et al.6

2003

413

GFR

12

 

 

Szeto et al. also showed that the peritoneal component of Kt/V or Ccr had no independent effect on any outcome parameter, but the renal component strongly correlated with patient outcome3.  Similarly, Rocco et al. used separate variables for the renal and peritoneal components of dialysis adequacy and found a decreased risk of death for both renal Ccr and Kt/V, but not for the peritoneal components4.  Data from the CANUSA study was re-analyzed by Bargman et al. to address this issue.  Once again they found a correlation between RRF and survival, but found no association with peritoneal clearance5.  The authors concluded that the most likely reason for the stronger association of renal function with patient survival was better renal clearance of higher molecular weight solutes when compared to peritoneal clearance.  Similarly, network registry data from the US and the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) confirmed the important contribution of RRF to the overall survival of HD patients7,8.

 

The PD studies attest to the fact that the peritoneal and renal components of clearance are not equivalent.  Therefore, we should raise the question – Is the contribution of peritoneal clearance important?  Obviously, the contribution of peritoneal clearance is clinically significant since anuric patients die within a very short period of time without dialysis and survive for up to many years on peritoneal dialysis.  Szeto et al. studied 140 anuric patients and found that even when there was no RRF, higher dialysis dosage was associated with better actuarial patient survival, better technique survival and shorter hospitalizations9.  They also pointed out that while both clinical impression and retrospective data suggest that renal and peritoneal clearances are not equivalent, their data strongly support that with progressive loss of RRF, an increase in PD dose can lead to better clinical outcomes.  In view of previous observations suggesting the superiority of RRF over PD dose it seems reasonable to intensify PD dose as renal function is lost. Of course, if the patients are started with an adequate dose of PD, disregarding the contribution of RRF, no adjustment in dose will be necessary upon loss of native renal function.

 

Based on these findings, the following recommendations are well justified:

  1. In the assessment of adequacy, both RRF and peritoneal clearances should be monitored periodically.
  2. Until the actual equivalence of the peritoneal and renal components of clearance are characterized, the loss of RRF should be replaced with an equivalent or higher dose of peritoneal clearance.
  3. Anuric patients should be rigorously monitored with particular attention to nutrition and their dose adjusted to the practical maximum.

 

Back to The Importance of RRF

 

Next

 

References:

 

  1. Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini C, Movilli E, Pola A, d'Avolio G, Gelatti U. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients.  A longitudinal study. Nephrol Dial Transplant 10:2295-2305, 1995
  2. Diaz-Buxo JA, Lowrie EG, Lew NL, et al.  Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis 33:523-534, 1999
  3. Szeto CC, Wong TYH, Leung CB, et al.  Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 58:400-407, 2000
  4. Rocco M, Soucie JM, Pastan S, McClellan WM.  Peritoneal dialysis adequacy and risk of death. Kidney Int 58:446-457, 2000
  5. Bargman JM, Thorpe KE, Churchill DN. The relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol 12:2158-2162, 2001
  6. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet R. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: An analysis of the netherlands cooperative study on the adequacy of dialysis (Necosad)-2. Am J Kidney Dis 41:1293-1302, 2003
  7. Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 38:85-90, 2001
  8. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 15:1061-1070, 2004
  9. Szeto CC, Wong TYH, Chow KM, et al.  Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis.  J Am Soc Nephrol 12:355-360, 2001
Print  
© 2006-2012, Fresenius Medical Care North America. All Rights Reserved. | Terms of Use | Privacy Statement | Register | Login